Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC
在Omicron疫情高峰期，使用tixagevimab/cilgavimab（AZD7442）进行暴露前预防可预防异基因造血干细胞移植受者发生严重的SARS-CoV-2感染：一项SFGM-TC的多中心回顾性研究
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-022-01387-0
Jondreville, Ludovic; D'Aveni, Maud; Labussière-Wallet, Hélène; Le Bourgeois, Amandine; Villate, Alban; Berceanu, Ana; Bezsera, Silvia-Maria; Thiebaut, Anne; Boissard-Simonet, Marion; Legrand, Marlène; Cornillon, Jérôme; Rubio, Marie-Thérèse; Chevallier, Patrice; Nguyen, Stéphanie
SARS-CoV-2
发育与干细胞
炎症/感染
干细胞
细胞生物学
